Kenvue Desitin Maximum Strength Ointments
Brand: Kenvue
USD 18.96 — In stock
How to order
In stock — USD 18.96.
Prefer to order with a person? +1 855 932 4721 · info@priconmed.com · Contact us.
Variants
- Ointment, Maximum Strength, 4 oz, 36/cs — USD 231.29 — In stock — SKU 00071
- Ointment, Maximum Strength, 1oz, 6/pk — USD 18.96 — In stock — SKU 17204
Product intelligence — AI-assisted — defer to the manufacturer's IFU
01 — At a glance
Product overview
Kenvue Desitin Maximum Strength Ointment is a specialized topical barrier designed to protect minor wounds and treat diaper rash by sealing out wetness. As part of the Kenvue patient care line, this ointment is formulated for skin protection in both pediatric and general wound care settings.
- Brand
- Kenvue
- Form Type
- Ointment
- Strength
- Maximum Strength
- Packaging Option 1
- 4 oz, 36 per case
- Packaging Option 2
- 1 oz, 6 per pack
- Primary Applications
- Diaper rash, minor wound care, chapped skin
How to think about this product
When evaluating Kenvue Desitin Maximum Strength Ointment, procurement staff should consider the high-zinc or high-barrier concentration typical of 'maximum strength' designations compared to daily-use creams. The availability of both 1 oz travel-sized packs and 4 oz bulk cases allows for a choice between individual patient discharge use and routine floor stock. This non-sterile ointment is positioned for topical protection rather than deep wound management, making it a standard choice for pediatric units and long-term care facilities focusing on moisture-associated skin damage.
02 — Clinical applications
Where this product is used
Kenvue Desitin Maximum Strength Ointments is commonly used in:
- Diaper rash prevention in neonatal and pediatric units
- Moisture barrier protection for incontinent patients
- Topical protection for minor cuts and abrasions
- Relief for dry or chapped skin areas
- Minor burn protection in outpatient clinics
03 — People also ask
Frequently asked questions
Q01 Who manufactures Kenvue Desitin Maximum Strength Ointments?
Kenvue Desitin Maximum Strength Ointments is manufactured by Kenvue. PriconMed sources this item through authorized supply channels so the lot, packaging, and expiration date match what Kenvue ships from the factory.
Q02 What type options are available?
This product is offered in 2 variants based on type. Use the selector on this page (or the variant table) to see SKUs, current stock, and per-unit pricing for each option.
Q03 Is bulk or contract pricing available?
Yes. Verified facilities ordering full cases of Kenvue Desitin Maximum Strength Ointments — or building a standing order — can request a custom quote from our wholesale team and qualify for tiered pricing and net-30 terms.
Q04 How quickly does this ship?
In-stock orders for Kenvue Desitin Maximum Strength Ointments are handled at our St. Louis Park, Minnesota warehouse in 0–5 business days (3 PM CST cutoff) and arrive in 3–11 business days total, including 3–6 business days in transit. Ground shipping is a flat $9.99 and free on orders of $250 or more. You'll see the live in-stock count on this page; if the item is low, contact us for an ETA before placing a large order.
Q05 Can I return this product if it doesn't work for my facility?
Unopened, in-date medical supplies in original packaging can be returned within 60 days — return by mail with a free downloadable label, restocking fee $0 (none), and refunds are processed within 5 days of receipt. Sterile or opened items cannot be returned for infection-control reasons. See our Returns policy for the full process.
Q06 Is this HSA/FSA eligible?
Most medical supplies sold by PriconMed — including Miscellaneous — are eligible for purchase with HSA and FSA funds when used for a qualifying medical condition. Save your PriconMed invoice for reimbursement.
04 — Wholesale · For verified medical professionals
Need a bulk quote?
Ordering 5+ cases or stocking a facility? Our wholesale team can offer custom pricing, standing orders, and net-30 terms.
- Net-30 terms
- Custom pricing
- 1 business day response